A. Glode

发表

Ublituximab for the treatment of CD20 positive B-cell malignancies

L. Cooke, D. Mahadevan, H. Babiker, 2018, Expert opinion on investigational drugs.

Sacituzumab govitecan: breakthrough targeted therapy for triple-negative breast cancer

J. Diamond, W. Messersmith, A. Glode, 2019, Expert review of anticancer therapy.

Immune checkpoint inhibitors: Significant advancements in non-small cell lung cancer treatment.

A. Glode, Megan B May, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Antibody‐Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy

Taleen Jerjian, C. O’Bryant, A. Glode, 2016, Pharmacotherapy.

Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center

A. Glode, Garth Wright, Melissa L. Gamble, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

A. Glode, Megan B May, 2016, Cancer management and research.

Gemtuzumab Ozogamicin: Back Again

C. Selby, A. Glode, Lisa R. Yacko, 2019, Journal of the advanced practitioner in oncology.

Apalutamide: A new agent in the management of prostate cancer

A. Glode, Megan B May, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors

E. Lam, Jihye Kim, A. Tan, 2020, Clinical Cancer Research.

Novel Uses for Lipid-Lowering Agents

A. Glode, Megan B May, 2016, Journal of the Advanced Practitioner in Oncology.

Heart Failure Caused by Molecularly Targeted Therapies for Cancer

M. Wong, A. Jarkowski, A. Glode, 2011, Pharmacotherapy.

Blinatumomab: A novel, bispecific, T-cell engaging antibody.

A. Glode, Megan B May, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A Review of PI3K Inhibitors in B-Cell Malignancies

A. Glode, Emmeline C. Academia, L. Cannon, 2019, Journal of the advanced practitioner in oncology.

Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs

A. Glode, Megan B May, 2017, Pharmacotherapy.

Pilot Prehabilitation Program for Patients With Esophageal Cancer During Neoadjuvant Therapy and Surgery.

M. McCarter, S. Leong, T. Schefter, 2019, The Journal of surgical research.

Ramucirumab: A vascular endothelial growth factor receptor-2 inhibitor with activity in several malignancies.

A. Glode, Jennifer Grabowski, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Bcop, Pharmd, A. Glode, 2019 .

Olanzapine: An Antiemetic Option for Chemotherapy-Induced Nausea and Vomiting

A. Glode, Megan V. Brafford, 2014, Journal of the advanced practitioner in oncology.

Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma

A. Glode, Abigail Shockley, James A. Davis, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Ramucirumab: A vascular endothelial growth factor receptor-2 inhibitor with activity in several malignancies.

A. Glode, Jennifer Grabowski, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.